Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Goldenwell Biotech (GWLL) Inventory Average (2021 - 2025)

Goldenwell Biotech's Inventory Average history spans 5 years, with the latest figure at $174788.0 for Q3 2025.

  • For Q3 2025, Inventory Average changed 0.06% year-over-year to $174788.0; the TTM value through Sep 2025 reached $174788.0, changed 0.06%, while the annual FY2024 figure was $174825.5, 0.36% changed from the prior year.
  • Inventory Average reached $174788.0 in Q3 2025 per GWLL's latest filing, roughly flat from $174788.0 in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $203100.0 in Q3 2021 to a low of $154425.0 in Q2 2021.
  • Average Inventory Average over 5 years is $180002.4, with a median of $175024.5 recorded in 2023.
  • The largest YoY upside for Inventory Average was 27.96% in 2022 against a maximum downside of 11.78% in 2022.
  • A 5-year view of Inventory Average shows it stood at $199573.0 in 2021, then fell by 11.78% to $176058.0 in 2022, then decreased by 0.64% to $174938.0 in 2023, then decreased by 0.12% to $174732.5 in 2024, then rose by 0.03% to $174788.0 in 2025.
  • Per Business Quant, the three most recent readings for GWLL's Inventory Average are $174788.0 (Q3 2025), $174788.0 (Q2 2025), and $174788.0 (Q1 2025).